Phase I Study : Dose Escalation of Intravenous Weekly Paclitaxel in Association With Metronomic Administration of Cyclophosphamide.
Latest Information Update: 14 Feb 2019
At a glance
- Drugs Cyclophosphamide (Primary) ; Paclitaxel (Primary)
- Indications Cancer
- Focus Adverse reactions
Most Recent Events
- 19 Aug 2013 Planned end date changed from 1 Dec 2014 to 1 Dec 2013 as reported by ClinicalTrials.gov.
- 19 Aug 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 12 Feb 2013 Planned End Date changed from 1 Jan 2014 to 1 Dec 2014 as reported by ClinicalTrials.gov.